After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, SLNO falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Soleno Therapeutics Inc is $2.54B. A total of 2.39 million shares were traded on the day, compared to an average of 2.10M shares.
In the most recent transaction, Abingworth Bioventures VII LP bought 1,347,522 shares of SLNO for 82.15 per share on Aug 11 ’25. In a previous transaction on Jul 01 ’25, Hirano Patricia C sold 3,830 shares at 82.76 per share. SLNO shares that the insider owns now total 13,206.
Among the insiders who bought shares, PATRICIA HIRANO acquired of 3,830 shares on Jul 01 ’25 at a per-share price of $82.76. In another insider transaction, Hirano Patricia C sold 266 shares at $84.25 per share on Jun 24 ’25. Company shares held by the insider now total 17,036.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, SLNO has a high of $90.32 and a low of $41.50.
As of this writing, SLNO has an earnings estimate of $0.57 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $1.01 per share and a lower estimate of $0.25. The company reported an EPS of -$1.27 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SLNO’s latest balance sheet shows that the firm has $21.30M in Cash & Short Term Investments as of fiscal 2021. There were $457.00k in debt and $8.01M in liabilities at the time. Its Book Value Per Share was $9.21, while its Total Shareholder’s Equity was $17.79M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLNO is Buy with a score of 4.83.
